With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine

With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine

Source: 
Fierce Pharma
snippet: 

Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed.